AGREEMENT AND PLAN OF MERGER among INFINITY PHARMACEUTICALS, INC., MEI PHARMA, INC. and MEADOW MERGER SUB, INC. Dated as of February 22, 2023Merger Agreement • February 23rd, 2023 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of February 22, 2023, among Infinity Pharmaceuticals, Inc., a Delaware corporation (“Iris”), MEI Pharma, Inc., a Delaware corporation (“Meadow”), and Meadow Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Meadow (“Merger Sub”). Meadow, Merger Sub and Iris are each sometimes referred to herein as a “Party” and collectively as the “Parties”.
AGREEMENT AND PLAN OF MERGER among INFINITY PHARMACEUTICALS, INC., MEI PHARMA, INC. and MEADOW MERGER SUB, INC. Dated as of February 22, 2023Merger Agreement • February 23rd, 2023 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 23rd, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of February 22, 2023, among Infinity Pharmaceuticals, Inc., a Delaware corporation (“Iris”), MEI Pharma, Inc., a Delaware corporation (“Meadow”), and Meadow Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Meadow (“Merger Sub”). Meadow, Merger Sub and Iris are each sometimes referred to herein as a “Party” and collectively as the “Parties”.